Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,526 across all filing types
Latest filing 2016-08-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
关于重庆云阳县单采血浆站取得单采血浆许可证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the receipt of a plasma collection license by a subsidiary of the company. It is an official notice about a regulatory approval or permit, not a financial report, management change, or shareholder meeting material. The document length is only 413 characters, indicating it is a brief announcement. It does not contain financial data, management information, or voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-08-18 Chinese
投资者投诉管理制度(2016年8月)
Governance Information Classification · 95% confidence The document is titled as an "Investor Complaint Management System" for a company, detailing procedures and responsibilities related to handling investor complaints. It references relevant laws and regulatory guidelines but does not contain financial data, earnings, or report disclosures. It is a governance-related internal policy document about investor relations and complaint handling. It is not an announcement, report, or financial filing. Therefore, it fits best under Governance Information (CGR), which covers internal rules and governance practices.
2016-08-17 Chinese
2016年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016 年半年度报告全文" which translates to "2016 Semi-Annual Report Full Text." It contains detailed financial data, including revenue, net profit, cash flow, and segment analysis for the first half of 2016 (January to June). The document includes sections such as company overview, financial data and indicators summary, board report, business analysis, and financial statements. The length is substantial (15,000 characters), and it contains actual financial statements and substantive financial data and analysis. The document is clearly a comprehensive financial report for a period shorter than a full fiscal year, i.e., a half-year or interim report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-08-17 Chinese
2016年1-6月财务报表
Interim / Quarterly Report Classification · 95% confidence The document is titled as "2016 年1-6 月财务报表 (未经审计)" which translates to "2016 January to June Financial Statements (Unaudited)". It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and shareholders' equity changes for the half-year period ending June 30, 2016. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-08-17 Chinese
2016年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2016 半年度报告摘要' which translates to '2016 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also includes management discussion and analysis of business operations and strategic initiatives during the reporting period. The document is about 3907 characters long, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content aligns with an Interim / Quarterly Report, which covers a period shorter than a full fiscal year and includes actual financial statements and management commentary. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2016
2016-08-17 Chinese
第六届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Hualan Biological Engineering Co., Ltd. regarding the approval of the 2016 semi-annual report and related matters. It includes the Supervisory Board's confirmation that the half-year report was prepared and reviewed in compliance with laws and regulations, and that the report content is true and accurate. The document itself does not contain the financial statements or detailed financial data of the half-year report but rather announces the approval and review results. Given the short length (589 characters) and the nature of the content as an announcement of the report's approval rather than the report itself, this fits best under Regulatory Filings (RNS) as a compliance announcement rather than an Interim/Quarterly Report (IR).
2016-08-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.